Canon Medical Launches CT Solution to Quickly and Safely Image Patients With Viral Infectious Diseases

Deployable CT Solutions + Rapid Decontamination Can Help Hospitals Isolate Patients and Decontaminate the System for More Effective Care

In today’s challenging healthcare environment, radiology departments are often faced with the difficult decision of how to safely image patients who are suspected of being positive with infectious disease.

To help hospitals and institutions effectively utilize CT with these conditions, Canon Medical Systems USA, Inc. introduces a deployable CT with a rapid decontamination solution. The deployable system includes the Aquilion™ Prime SP CT system in a modular or mobile footprint with a rapid decontamination tool, to help isolate and decontaminate the CT for rapid, safe imaging.

The Aquilion Prime SP CT system offers complete clinical capability, with advanced imaging technology from Canon Medical’s high-end CT systems with the right balance between image quality and lower dose for every patient. The system can generate 160 unique slices per rotation with 0.35-second scanning, reducing time required to perform studies for compromised patients, and also increase throughput. With a 78-cm aperture gantry and a 660-pound patient-weight-capacity couch, the system is ideal for use in an emergency setting. The Aquilion Prime SP is now also available with Advanced Intelligent Clear-IQ Engine (AiCE) Deep Learning Reconstruction (DLR), enabling clinicians to enhance diagnostic confidence at low doses. Now available in a modular or mobile setup for easy deployment, the system can be isolated from other facility staff and patients, providing a safer environment for imaging patients suspected to have infectious diseases.

The decontamination system is an automated UV-C technology that significantly reduces bacteria, spores and viruses and is effective against a variety of advanced viral infectious diseases. The system incorporates multiple automated UV-C emitters that work together to provide decontamination of the room in minutes to help improve workflow. The decontamination system is available for the new deployable CT solutions, as well as existing fixed imaging suites.

“Imaging infectious disease patients is not a new phenomenon for medical providers. But our customers are facing an unprecedented number of potentially contagious patients,” said Erin Angel, managing director, CT Business Unit, Canon Medical Systems USA, Inc. “Our deployable CT offerings with the addition of rapid UV-C decontamination will offer providers a unique solution to help improve their workflow and safety as they image infectious disease patients.”

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version